Share Price:GBX

Day Change:

Trading suspended

Click for more information

AIM symbol: REDX
Issued Shares: 126,477,914
Market Cap: £40.95M

Quoted at 23:07:07 BST on 21 July 2017    Data is delayed by 15+ minutes    The London Stock Exchange is currently closed

Company Summary

Redx Pharma is an established drug discovery and development company, formed in late 2010. The Group is focused on the development of proprietary, small molecule therapeutics to address areas of high unmet medical need principally in cancer, immunology and infection. Redx Pharma's work has been endorsed by major partnerships with global pharmaceutical companies and the NHS.

Latest Regulatory News

MHRA approval of Clinical Trial Application 23 Jun 2017   14:38
Update on Suspension of Trading 22 Jun 2017   07:00
Statement re. Suspension 24 May 2017   18:35
AIM - Suspension - Redx Pharma plc 24 May 2017   16:35
Interim results for six months ended 31 March 2017 17 May 2017   07:00

Share price data and investor tools provided by Brighter IR, subject to their Terms & Conditions

More Regulatory News

Latest Publication

poster preview image of 2017 iwCLL: RXC005, a Potent and Selective, Reversible BTK Inhibitor Targeting both Wild-type and Mutant C481S BTK with Potent Efficacy in ABC-DLBCL Xenograft Mouse Models

RXC005, a Potent and Selective, Reversible BTK Inhibitor Targeting both Wild-type and Mutant C481S BTK,
15 May 2017

Latest Video

ProactiveInvestors, 17 May 2017

Redx Pharma “in a very good place with great assets”